FHU ONCOAGE

High-level research and innovation activities aim to produce positive outcomes
Skip to content
  • Home
  • What is ONCOAGE ?
    • Who are we?
    • Our teams
    • Objectives
    • Milestones & Achievement
    • Scientific Advisory Board
  • Platforms
    • Research
    • Technological innovations
  • Partners / Ecosystem
    • The Consortium
    • Teaching and Training activities
    • Industrial collaborations
  • Work Packages
    • Model Pathologies
    • Underlying Mechanisms
    • Support & Output
  • News and Events
    • Events
    • News
  • Contact
    • Join us
    • Donate
    • Contact us
  • Intranet

NSCLC: Liquid Biopsy May Predict Patient Response to Immune Checkpoint Inhibition

Posted on 25 October 20176 May 2019 by Ariane Capdevielle

NSCLC: Liquid Biopsy May Predict Patient Response to Immune Checkpoint Inhibition

PD-L1 status in circulating tumor cells (CTCs) and white blood cells (WBCs) correlates with PD-L1 status in non–small cell lung cancer (NSCLC) tissues, according to recently published research.1

Read more >
News   Biopsy, Immune, tumor cells
  • Legals
  • Contact us

® FHU ONCOAGE 2014 - 2024